Proposed Release No. 33-11418 would significantly expand Form S-3 access for domestic issuers while preserving legacy Form F-3 and WKSI ...
VANCOUVER, British Columbia--(BUSINESS WIRE)-- Zymeworks Inc. (NYSE: ZYME), a clinical‑stage biopharmaceutical company developing multifunctional therapeutics, announced today that it has filed an ...
The automated shelf-scanning technology enables the major retailer to dynamically identify out-of-stocks and pricing errors — eliminating reliance on manual corrections while boosting planogram ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results